Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition
Source: SeekingAlpha
2026-02-23 11:58:36 ET
Thesis
Tandem Diabetes Care, Inc. ( TNDM ) beat out expectations in Q4 '25. GAAP EPS came in at -$0.01, which was actually $0.05 above the consensus. Elsewhere, revenue for the quarter hit $290.4 million, up about 2.8% year-over-year and $13.16 million ahead of forecasts. There were much stronger-than-expected sales in both the U.S. and international markets, with the market caution coming from a new pay-as-you-go model for customers....
Read the full article on Seeking Alpha
For further details see:
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition
Tandem Diabetes Care Inc.
NASDAQ: TNDM
TNDM Trading
-4.09% G/L:
$20.40 Last:
534,185 Volume:
$20.60 Open:
TNDM Latest News
February 25, 2026 12:30:00 am
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
February 23, 2026 06:33:18 pm
Exposure Surge, Immunotherapy Expansion, and a $1.1B Healthcare Takeout
February 23, 2026 04:05:00 pm
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
TNDM Stock Data
$1,337,401,531
66,514,114
0.48%
99
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
